5-Lipoxygenase activity in the human pancreas

Area of Science:

• Biochemistry
• Human Physiology

Background:

• Low levels of 5-lipoxygenase (5-LO), the key enzyme in leukotriene (LT) synthesis, have been previously observed in porcine pancreas.
• Leukotrienes play roles in inflammatory processes, and their synthesis pathway involves 5-LO and 5-lipoxygenase-activating protein (FLAP).

Purpose of the Study:

• To quantify 5-lipoxygenase (5-LO) activity in human pancreas subcellular fractions.
• To investigate the characteristics and localization of 5-LO within human pancreatic tissue.
• To determine the presence of 5-lipoxygenase-activating protein (FLAP) in the human pancreas.

Main Methods:

• Subcellular fractionation of human pancreas samples.
• Assay of 5-lipoxygenase (5-LO) activity in different fractions.
• Western blot analysis for 5-LO and 5-lipoxygenase-activating protein (FLAP) detection.
• Measurement of enzyme activity with and without arachidonic acid (AA) addition.

Main Results:

• 5-lipoxygenase (5-LO) activity was detectable in all human pancreas samples, though at lower levels than in human leukocytes.
• The highest specific activity of pancreatic 5-LO was found in membrane fractions.
• Pancreatic 5-LO activity did not necessitate the addition of arachidonic acid (AA), suggesting the presence of endogenous unesterified AA.
• Western blot confirmed the presence of both 5-LO and 5-lipoxygenase-activating protein (FLAP) in human pancreas, albeit at low levels.

Conclusions:

• The human pancreas possesses 5-lipoxygenase (5-LO) activity, primarily localized to membrane fractions.
• Endogenous unesterified arachidonic acid (AA) likely contributes to the observed pancreatic 5-LO activity.
• Low levels of 5-LO and FLAP in the human pancreas suggest a potentially limited role in leukotriene synthesis compared to leukocytes.